HIGH

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Quick Facts at a Glance

Recall Date
March 16, 2026
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Geographic Scope
1 states

Hazard Information

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for CINACALCET recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02. Generic: CINACALCET; Brand: CINACALCET. Reason: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit. Classification: Class II. Quantity: 63,192 bottles. Distribution: Nationwide in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot
expiry: 4PB0224
exp March-2026
4PB0505
4PB0506
+4 more
UPC Codes
69097-410
69097-411
69097-412
+3 more
Affected States
ALL
Report Date
April 22, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls